Along with recent guidelines, pharmacists can use their skills to improve outcomes in these patients, such as ensuring appropriate medication timing and administration.
The focus of new agents for treating this malignancy has been on patients with relapsed or refractory disease, which carries a poor prognosis and short life expectancy.